Clinical Trial Update: Digital Remote Monitoring of Immune Checkpoint Inhibitor Therapy Induced Toxicity Using the Vigilant App

View source ↗

Summary

This clinical trial is evaluating digital remote monitoring of immune checkpoint inhibitor–related toxicity using the Vigilant App. The study targets patients w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma
• Skin Cancer

Snippet

Sponsor: Mayo Clinic | Conditions: Malignant Skin Neoplasm, Melanoma | Status: RECRUITING